Nuvation Bio Inc.

This program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…

This study is testing a new drug called NUV-1511 in adults with advanced solid tumors that have stopped responding to standard treatments. The first part checks the drug's safety and finds the right dose, while the second part looks at how well it shrinks tumors in specific cance…

This study is testing a new oral medication called AB-106 for people with advanced non-small cell lung cancer that has a specific genetic change called ROS1 fusion. The trial aims to find the best dose and see how safe and effective the drug is for 173 patients, including those w…

This study is testing an oral medication called taletrectinib for people with advanced lung cancer that has a specific genetic change called ROS1. The trial aims to see how well the drug shrinks tumors and how safe it is for patients, including those who have or haven't had simil…